October 31 (SeeNews) - Bulgarian drug maker Sopharma [BUL:SFA] said its standalone net profit jumped to 38.4 million levs ($20.8 million/19.6 million euro) in the first nine months of 2023 from 23.8 million levs in the same period last year.